Curaleaf Holdings, Inc.: Form 40-F for the period ended Dec 31, 2025
Filed with the SEC on Feb 27, 2026 and accepted by EDGAR at Feb 26, 2026, 20:10 ET.
Sections
Sections are extracted only from 10-K and 10-Q reports. Read this filing’s documents on sec.gov. The main document on sec.gov.
Figures reported in this filing
Standardized line items from the XBRL in this filing, for the period ended 2025-12-31. Comparative periods it repeats are left out.
| Line item | Period | Value | XBRL concept |
|---|---|---|---|
| Revenue | 12 months2025-01-01 to 2025-12-31 | $1.27bn | us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax |
| Cost of revenue | 12 months2025-01-01 to 2025-12-31 | $637.1m | us-gaap:CostOfGoodsAndServicesSold |
| Gross profit | 12 months2025-01-01 to 2025-12-31 | $631.0m | us-gaap:GrossProfit |
| Research and development | 12 months2025-01-01 to 2025-12-31 | $805.0k | us-gaap:ResearchAndDevelopmentExpense |
| Selling, general and administrative | 12 months2025-01-01 to 2025-12-31 | $428.4m | us-gaap:SellingGeneralAndAdministrativeExpense |
| Operating income | 12 months2025-01-01 to 2025-12-31 | $25.4m | us-gaap:OperatingIncomeLoss |
| Income tax | 12 months2025-01-01 to 2025-12-31 | $123.7m | us-gaap:IncomeTaxExpenseBenefit |
| Net income | 12 months2025-01-01 to 2025-12-31 | −$231.1m | us-gaap:NetIncomeLoss |
| Diluted EPS | 12 months2025-01-01 to 2025-12-31 | −$0.35 | us-gaap:EarningsPerShareDiluted |
| Basic EPS | 12 months2025-01-01 to 2025-12-31 | −$0.35 | us-gaap:EarningsPerShareBasic |
| Diluted shares (weighted) | 12 months2025-01-01 to 2025-12-31 | 762,090,951 shares | us-gaap:WeightedAverageNumberOfDilutedSharesOutstanding |
| Operating cash flow | 12 months2025-01-01 to 2025-12-31 | $137.7m | us-gaap:NetCashProvidedByUsedInOperatingActivities |
| Capital expenditure | 12 months2025-01-01 to 2025-12-31 | $63.4m | us-gaap:PaymentsToAcquirePropertyPlantAndEquipment |
| Current assets | At period end2025-12-31 | $448.6m | us-gaap:AssetsCurrent |
| Total assets | At period end2025-12-31 | $2.85bn | us-gaap:Assets |
| Current liabilities | At period end2025-12-31 | $294.3m | us-gaap:LiabilitiesCurrent |
| Total liabilities | At period end2025-12-31 | $2.01bn | us-gaap:Liabilities |
| Long-term debt | At period end2025-12-31 | $512.9m | us-gaap:LongTermDebtNoncurrent |
| Current portion of debt | At period end2025-12-31 | $35.7m | us-gaap:LongTermDebtCurrent |
| Shareholders' equity | At period end2025-12-31 | $756.4m | us-gaap:StockholdersEquity |
Source: SEC EDGAR, the filing index for accession 0001756770-26-000019. Last ingested by Listed: Nov 10, 2026, 22:51 ET. Listed shows no prices and gives no investment advice.